BIOLINERX LTD's ticker is BLRX and the CUSIP is 09071M205. A total of 19 filers reported holding BIOLINERX LTD in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $98,634 | -13.6% | 61,840 | -52.0% | 0.42% | +16.4% |
Q1 2023 | $114,114 | -99.7% | 128,725 | +169.0% | 0.36% | +113.5% |
Q3 2022 | $44,270,000 | -86.5% | 47,860 | -70.2% | 0.17% | -85.7% |
Q4 2021 | $327,134,000 | +55.5% | 160,360 | +109.6% | 1.20% | +89.8% |
Q3 2021 | $210,402,000 | – | 76,510 | – | 0.63% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 1,686,375 | $2,884,000 | 0.18% |
Senvest Management, LLC | 451,205 | $772,000 | 0.05% |
Cutter & CO Brokerage, Inc. | 17,799 | $30,000 | 0.01% |
Opaleye Management Inc. | 16,667 | $29,000 | 0.01% |
Psagot Value Holdings Ltd. | 117,000 | $200,000 | 0.01% |
Orbimed Advisors | 69,240 | $118,000 | 0.00% |
MORGAN STANLEY | 565,114 | $966,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 18,973 | $32,000 | 0.00% |
LPL Financial LLC | 19,876 | $34,000 | 0.00% |
Asset Dedication, LLC | 366 | $1,000 | 0.00% |